Transcriptome analysis further revealed that COL8A1 was highly expressed in tumor samples and stage III/IV, as well as closely correlated with shorter survival time, underscoring its highly malignant behavior (Fig. 5A-B and Figure S7A), which was validated by clinical CRC samples (Fig. 5C-D). This evidence concerns the gene COL8A1 and neoplasm.